ML18085A070
| ML18085A070 | |
| Person / Time | |
|---|---|
| Site: | 03037592 |
| Issue date: | 03/12/2018 |
| From: | Gaskins F C NRC Region 1 |
| To: | Boone Memorial Hosp |
| References | |
| 602389 | |
| Download: ML18085A070 (3) | |
Text
NRC FORM374 U.S. NUCLEAR REGULATORY COMMISSION MATERIALS LICENSE PAGE 1 OF 3 PAGES Amendment No. 9 Pursuant to the Atomic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Public Law 93-438), and Title 10, Code of Federal Regulations, Chapter I, Parts 30, 31, 32, 33, 34, 35, 36, 37, 39, 40, 70 and 71, and in reliance on statements and representations heretofore made by the licensee, a license is hereby issued authorizing the licensee to receive, acquire, possess, and transfer byproduct, source, and special nuclear material designated below; to use such material for the purpose(s) and at the place(s) designated below; to deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part(s). This license shall be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954, as amended, and is subject to all applicable rules, regulations, and orders of the Nuclear Regulatory Commission now or hereafter in effect and to any conditions specified below. Licensee 1. Boone Memorial Hospital, Inc. 2. 701 Madison Avenue Madison, VW 25130 6. Byproduct, source, and/or special nuclear material A. Any byproduct material permitted by 1 O CFR 35.100 8. Any byproduct material permitted by 1 O CFR 35.200 7. A. B. Chemical and/or physical form Any Any In accordance with letter dated February 02,2018. 3. License number: 47-31291-01 is renewed in its entirety to read as follows: 8. Maximum amount that licensee may possess at any one time under this license .. A. As Needed 8. As Needed CONDITIONS
- 4. Expiration Date: March 31, 2033 5. Docket No.: 030-37592 Reference No.: 9. Authorized use A. For use in uptake, dilution and excretion studies permitted by 10 CFR 35.100. 8. For use in imaging and localization studies permitted by 10 CFR 35.200. 10. Licensed material may be used or stored at the licensee's facilities located at 701 Madison Avenue, West Virginia.
- 11. The Radiation Safety Officer (RSO) for this license is James T. Norweck, M.S.
NRC FORM 374A U.S. NUCLEAR REGULATORY COMMISSION PAGE 2 OF 3 PAGES License Number Docket or Reference Number MATERIALS LICENSE 47-31291-01 030-37592 SUPPLEMENTARY SHEET Amendment No. 9 12. Licensed material shall only be used by, or under the supervision of: A. Individuals permitted to work as authorized users iri accordance with 10 CFR 35.13 and 10 CFR 35.14. B. Licensed material shall only be used by, or under the supervision of: Authorized Users Material and Use Robert Davis, M.D. 10 CFR 35.100,10 CFR 35.200 Elie Gharib, M.D. 10 CFR 35.200 Casey Shawn Hager, M.D 10 CFR 35.200 Mitchell Rashid, M.D. 10 CFR 35.200 13. In addition to the possession limits in Item 8, the licensee shall further restrict the possession of licen.sed material to quantities below the minimum limit specified in 10 CFR 30.35(d) for establishing decommissioning financial assurance.
NRC FORM 374A U.S. NUCLEAR REGULATORY COMMISSION PAGE 3 OF 3 PAGES MATERIALS LICENSE SUPPLEMENTARY SHEET License Number 47-31291-01 Amendment No. 9 Docket or Reference Number 030-37592
- 14. Except as specifically provided otherwise in this license, the licensee shall conduct its program in accordance with the statements, representations, and procedures contained in the documents, inc,luding any enclosures, listed below. This license condition applies only to those procedures that are required to be submitted in accordance with the regulations.
Additionally, this license condition does not limit the licensee's ability to make changes to the radiation protection program as provided for in 10 CFR 35.26. The U.S. Nuclear Regulatory Commission's regulations shall govern unless the statements, representations, and procedures in the licensee's application and correspondence are more restrictive than the regulations.
A. Application dated February 2, 2018 [MU 80469267]
B. Letter dated March 1, 2018 [ML 18067 A243] Date: March 12, 2018 FOUS NUCLEAR REGULATORY COMMISSION By. JJAL C\JJ;, Farrah Gaskins Region 1 ' -